Importance of building Australia-China biotech collaborations

By Karen Loudon / November 1, 2023
China is Australia’s greatest two-way trading partner in products and services, making up close to one-third of the nation's international...
Read More

Life Science Success podcast with Prof. Alan Trounson

By Karen Loudon / October 20, 2023
Cartherics’ CEO, Prof. Alan Trounson, was recently a guest on Life Science Success podcast. Hosted by Dr Don Davies, this...
Read More

Cartherics appoints new Chief Scientific Officer

By Karen Loudon / October 17, 2023
Melbourne, Australia, 17 October 2023 –  Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing immune cell therapies for...
Read More

Ovarian cancer is not ovarian cancer

By Karen Loudon / October 3, 2023
Cartherics’ Dr Ian Nisbet (Chief Operating Officer) and Kathy Skoff (Clinical Trials Manager) recently attended an ovarian cancer symposium in...
Read More

Combining new and existing immunity: a 3D approach to killing cancer

By Karen Loudon / September 25, 2023
by Richard Boyd and Aleta Pupovac A question which has long baffled scientists, frustrated clinicians and devastated patients is why...
Read More

Heather Hawkins Ovarian Cancer Journey

By Karen Loudon / August 24, 2023
Heather Hawkins, Cartherics Board Advisor and patient advocate, shares her personal journey with ovarian cancer in the hope that it...
Read More

Bio Connections Australia 2023 promotes science commercialisation

By Karen Loudon / July 31, 2023
Commercialising science and technology is key to the continued growth of Australia’s vibrant life sciences industry. Translating research into real-world...
Read More

Australia – China Science and Innovation Forum fosters collaboration and commercialisation

By Karen Loudon / June 28, 2023
The 2023 Australia-China Science and Innovation Forum focused on leading-edge Australian and Chinese biomedical research collaborations and commercialisation. The forum...
Read More

Cell Therapy Potency Assay Summit reveals exclusive insights on regulatory interactions and potency assay development

By Karen Loudon / June 16, 2023
Cartherics’ Acting Chief Scientific Officer, Dr Walid Azar recently attended the 2nd Cell Therapy Potency Assay Summit in Boston. The...
Read More

Global IP takes centre stage at the 21st Advanced Summit on Life Sciences Patents

By Karen Loudon / May 30, 2023
Cartherics’ Director of IP & Licensing, Telma Mantas recently attended the ACI’s 21st Advanced Summit on Life Sciences Patents in...
Read More

Cartherics to present at the 2023 BIO International Convention

By Karen Loudon / May 24, 2023
Melbourne, Australia, 24 May 2023 – Cartherics Pty Ltd, a biotechnology company developing immune cell therapies for the treatment of...
Read More

Cartherics congratulates Rasa Islam on PhD success

By Karen Loudon / May 16, 2023
Cartherics is delighted to announce that Rasa Islam has successfully completed her PhD candidature. Rasa’s research thesis, titled, Re-engineering the...
Read More

Cartherics to present at the CIMT Annual Meeting in Germany

By Karen Loudon / May 2, 2023
Cartherics is pleased to announce that PhD Candidate, Van To, will be presenting at the Association for Cancer Immunotherapy’s 20th...
Read More

Cartherics grants Shunxi Licence for CAR-T Cell Therapy for Ovarian Cancer in Greater China

By Karen Loudon / April 28, 2023
Melbourne, Australia, 28 April 2023 –  Cartherics Pty Ltd ("Cartherics"), a biotechnology company developing immune cell therapies for the treatment...
Read More

Cartherics’ offsite provides the opportunity to connect, engage and grow

By Karen Loudon / April 14, 2023
Cartherics recently held a company offsite at the RACV Healesville Country Club and Resort. Nestled in the beautiful Yarra Valley...
Read More